Depression

Depression is a clinical syndrome characterized by persistent low mood, loss of interest or pleasure, and reduced energy that interferes with daily functioning. When symptoms are sustained and severe enough to impair function, the presentation can meet criteria for a depressive disorder.

Overview

Depression is more than transient sadness or grief. It is a clinical syndrome involving sustained changes in mood, motivation, cognition, sleep, appetite, and energy that, when severe and persistent, meet criteria for a diagnosable depressive disorder.

The American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) categorizes depressive disorders to include major depressive disorder, persistent depressive disorder (formerly dysthymia), premenstrual dysphoric disorder, disruptive mood dysregulation disorder, and substance- or medical-condition-induced depressive disorders. Each has distinct diagnostic criteria but shares the central feature of clinically significant low mood or loss of interest leading to functional impairment.

Depression is among the most common mental health conditions globally. The U.S. National Institute of Mental Health reports a lifetime prevalence in adults of approximately 21%, with women diagnosed at roughly twice the rate of men. The World Health Organization estimates 280 million people worldwide currently live with depression. Onset can occur at any age but is most common in late adolescence through middle adulthood.

Course varies widely. Some individuals experience a single episode that resolves with or without treatment; others have recurrent episodes throughout life; and others develop a chronic, lower-grade form (persistent depressive disorder) that may last for years. Without treatment, an episode of major depression typically lasts six to nine months, and roughly half of individuals who experience one episode go on to experience another.

Untreated depression carries significant costs. It is associated with reduced occupational and academic functioning, relationship disruption, increased medical comorbidity (cardiovascular disease, diabetes, chronic pain), elevated risk of substance use disorders, and — most critically — increased risk of suicide. Depression is the leading cause of disability worldwide.

The condition responds well to a range of evidence-based treatments. Approximately 60% to 80% of individuals with depression who engage in adequate treatment experience clinically significant improvement, and many achieve remission. Treatment selection depends on severity, episode count, comorbidity, individual preference, and access.

Signs and symptoms

Persistent depressed mood — A sustained low, sad, empty, or hopeless mood occurring most of the day, nearly every day, lasting at least two weeks.
Anhedonia — Markedly diminished interest or pleasure in activities that were previously enjoyable.
Fatigue or loss of energy — A pervasive sense of being drained or exhausted, often disproportionate to activity level.
Sleep disturbance — Insomnia (difficulty falling or staying asleep, early waking) or hypersomnia (excessive sleep that does not feel restorative).
Appetite or weight changes — Significant decrease or increase in appetite, often with corresponding weight loss or gain not attributable to dieting.
Difficulty concentrating — Reduced ability to think, focus, retain new information, or make decisions.
Feelings of worthlessness or guilt — Excessive or inappropriate self-criticism and guilt, sometimes about events long past.
Psychomotor changes — Observable agitation (restlessness, pacing) or slowing (reduced speech, slowed movement) noticeable to others.
Suicidal ideation — Recurrent thoughts of death, passive wishes to be dead, or active suicidal ideation, with or without a plan.
Cognitive distortion — Pervasive negative thinking patterns, including hopelessness about the future and a tendency to interpret neutral events negatively.

Diagnostic context

Major depressive disorder (MDD) in the DSM-5-TR requires at least five of nine core symptoms during the same two-week period, with at least one being depressed mood or loss of interest. Symptoms must cause clinically significant distress or impairment and not be attributable to a substance, medical condition, or other psychiatric disorder. Severity is graded mild, moderate, or severe based on symptom count, intensity, and functional impact.

Persistent depressive disorder (PDD) requires depressed mood for most of the day, more days than not, for at least two years (one year in children and adolescents), with at least two additional symptoms. PDD captures chronic, lower-grade depressive presentations that may have been called dysthymia in earlier nosology.

Diagnosis is made by a qualified clinician through structured assessment. Common screening instruments include the PHQ-9 (Patient Health Questionnaire), the Beck Depression Inventory (BDI-II), and the Hamilton Depression Rating Scale (HDRS). Screening tools support but do not replace clinical diagnosis. Bipolar disorder must be ruled out, as treatment differs substantially.

Causes and risk factors

Depression arises from the interaction of biological, psychological, and environmental factors. No single cause is identified, and the relative contribution of each varies between individuals.

Genetic and biological factors

First-degree relatives of individuals with major depression have a two- to three-fold increased risk of the disorder. Twin studies estimate heritability at approximately 30% to 40%. Neuroimaging consistently demonstrates altered functional connectivity in prefrontal-limbic circuits, with reduced activation in regions associated with reward processing and emotion regulation. Dysregulation of serotonergic, noradrenergic, and dopaminergic neurotransmission, as well as hypothalamic-pituitary-adrenal (HPA) axis dysfunction, are implicated in symptom maintenance.

Psychological and temperamental factors

High trait neuroticism, a tendency toward negative cognitive styles (rumination, hopelessness), and insecure attachment are well-established psychological risk factors. Cognitive theories emphasize the role of stable, internal, global negative attributions in shaping vulnerability.

Environmental and life-course factors

Adverse childhood experiences, including loss, abuse, neglect, and chronic invalidation, substantially increase later risk. Recent stressors — bereavement, relationship dissolution, job loss, financial precarity, chronic illness, caregiver burden — frequently precede onset. Social isolation, chronic discrimination, and minority stress are recognized environmental contributors.

Medical and substance contributors

Several medical conditions can produce depressive symptoms, including hypothyroidism, vitamin B12 or vitamin D deficiency, chronic pain, sleep apnea, Parkinson’s disease, and certain cancers. Alcohol use, sedative withdrawal, and several medications (including some antihypertensives and corticosteroids) can produce or amplify depression. Medical evaluation is appropriate when depressive symptoms emerge alongside physical complaints or in mid-life without obvious psychosocial trigger.

Typical treatments

Depression responds to a well-evidenced range of treatments. Selection depends on severity, episode history, prior treatment response, comorbidity, and individual preference.

Psychotherapy. Several modalities have strong evidence: cognitive behavioural therapy (CBT), behavioural activation (BA), interpersonal therapy (IPT), acceptance and commitment therapy (ACT), and mindfulness-based cognitive therapy (MBCT, particularly for relapse prevention). Treatment is typically delivered in 12 to 20 sessions. For mild-to-moderate depression, psychotherapy alone is comparable in efficacy to pharmacotherapy.

Pharmacotherapy. First-line agents include selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). Atypical antidepressants (bupropion, mirtazapine), tricyclic antidepressants, and monoamine oxidase inhibitors are reserved for second-line or treatment-resistant cases. Initial response typically emerges over four to six weeks. Pharmacological decisions should be made with a physician or psychiatrist, considering medical history, side-effect profile, suicide risk, and pregnancy status.

Combined treatment. For moderate-to-severe depression, combining psychotherapy with pharmacotherapy yields better outcomes than either alone, particularly for individuals with high baseline severity, recurrent episodes, or significant comorbidity.

Neuromodulation. For treatment-resistant depression, evidence-based options include repetitive transcranial magnetic stimulation (rTMS), electroconvulsive therapy (ECT), and ketamine or esketamine. These are typically reserved for individuals who have not responded to two or more adequate trials of standard treatment.

Lifestyle and adjunctive interventions. Regular aerobic exercise has demonstrable antidepressant effects in mild-to-moderate depression and is recommended as an adjunct in most treatment guidelines. Sleep regularization, reduction of alcohol use, sunlight exposure (or light therapy for seasonal patterns), and social engagement support recovery.

When to seek help

Professional consultation is warranted when low mood, loss of interest, or related symptoms persist for more than two weeks, when they cause measurable interference with work, school, relationships, or daily functioning, or when they are accompanied by thoughts of death, hopelessness, or self-harm. Earlier intervention reduces episode duration and lowers risk of recurrence.

Immediate help is indicated when there is suicidal ideation with intent or a plan, when daily self-care has become impossible, or when psychotic symptoms are present. Mental-health crisis services should be contacted in any of these situations.

In Canada, free 24-hour mental-health support is available through 9-8-8: Suicide Crisis Helpline (call or text 988) and Talk Suicide Canada (1-833-456-4566). Provincial crisis lines and Health Link 811 (Alberta) provide additional triage. A general practitioner is an appropriate first contact for non-urgent depressive symptoms and can provide referral to qualified psychologists, psychotherapists, or psychiatrists.

Frequently asked questions

How is depression different from sadness or grief?

Sadness and grief are normal responses to loss or disappointment and tend to be tied to specific events and to fluctuate over time. Depression is more pervasive, persistent (lasting at least two weeks), and accompanied by additional symptoms such as anhedonia, fatigue, sleep and appetite disturbance, and impaired functioning. Grief and depression can co-occur but are distinguished by clinical assessment.

Can depression go away on its own?

Some depressive episodes resolve without formal treatment, though average episode duration without intervention is six to nine months and recurrence is common. Treatment shortens episode duration, reduces severity, and lowers the risk of future episodes.

Is depression caused by a chemical imbalance?

The "chemical imbalance" framing is an oversimplification. Depression involves complex interactions between neurotransmitter systems, brain circuit function, genetics, psychological patterns, and environment. Antidepressant medications affect specific neurotransmitter systems, but the full mechanism of action is incompletely understood and not reducible to correcting a single imbalance.

Do antidepressants work for everyone?

Approximately 50% to 60% of individuals respond to the first antidepressant they try, and many who do not respond to one will respond to another or to combination strategies. Roughly one-third of individuals do not achieve full remission with standard pharmacotherapy alone, which is why combined or alternative approaches (psychotherapy, neuromodulation) are important.

How long does treatment take?

Initial response to medication or psychotherapy typically emerges within four to six weeks, with continued improvement over three to six months. Treatment guidelines recommend continuing antidepressants for at least six months after symptom remission to reduce relapse risk; for recurrent depression, longer-term maintenance may be advised.

When should I seek help?

When depressive symptoms persist for more than two weeks, interfere with daily functioning, or are accompanied by thoughts of death or self-harm. Earlier intervention is associated with better outcomes and lower relapse risk.

References

Find the pattern behind what's been feeling hard

A few simple questions to help surface the concerns that may fit best.

Find Your Pattern

Therapy for Depression

Connect with a ShiftGrit therapist at one of our locations:

Find a Therapist by Province

Browse therapy options by province to see which clinicians are available to work with clients in your region.

Depression therapists in Alberta Depression therapists in Ontario

Trusted by Leading Psychology & Mental Health Organizations Across Canada

ShiftGrit Psychology & Counselling is professionally regulated, certified, and recognized by leading psychology and mental-health organizations across Canada. These associations reflect our commitment to ethical practice, clinical standards, and evidence-informed therapy through Identity-Level Therapy and Reconditioning.

Trusted By Alberta’s Leading Psychology & Mental Health Organizations

ShiftGrit Psychology & Counselling is professionally regulated, certified, and recognized by leading psychology and mental-health organizations across Alberta and Canada. These associations reflect our commitment to ethical practice, clinical standards, and evidence-informed therapy through Identity-Level Therapy and Reconditioning.

Regulated and affiliated across Alberta’s leading psychology, counselling, and mental-health organizations.

Regulated and affiliated across Canada’s leading psychology, counselling, and mental-health organizations.

Authored by

ShiftGrit Clinical Editorial Team

The ShiftGrit Clinical Editorial Team combines the insight of registered psychologists, provisional psychologists, and trained writers to create accessible, evidence-informed therapy resources. All content is clinically reviewed by a Registered Psychologist.